COVID-19 Seroprevalence in Pregnant Women and Blood Donors

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The study aims to measure the SARS-CoV-2 seroprevalence (ie. the proportion of people with antibodies against the virus) in pregnant women and blood donors in an administrative area of France, and to determine whether these measures are representative of the general population.
Epistemonikos ID: 6425ef6e796d06f205baffee69db1bc9c53a9a92
First added on: May 20, 2021